본문 바로가기
KERD
논문KCI 등재

Congenital hyperinsulinism: current status and future perspectives

Tohru Yorifuji
대한소아내분비학회 (Korean Society Of Pediatric Endocrinology)|2014.06|Annals of Pediatric Endocrinology & Metabolism|제19권 제2호|pp. 57-68

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

CongenitalHypoglycemiaHyperinsulinism
주제분류소아과학

초록

The diagnosis and treatment of congenital hyperinsulinism (CHI) have made a remarkable progress over the past 20 years and, currently, it is relatively rare to see patients who are left with severe psychomotor delay. The improvement was made possible by the recent developments in the understanding of the molecular and pathological basis of CHI. Known etiologies include inactivating mutations of the K ATP channel genes (ABCC8 and KCNJ11) and HNF4A, HNF1A, HADH, and UCP2 or activating mutations of GLUD1, GCK, and SLC16A1. The understanding of the focal form of K ATP channel CHI and its detection by 18 F-fluoro-L-DOPA positron emission tomography have revolutionized the management of CHI, and many patients can be cured without postoperative diabetes mellitus. The incidence of the focal form appears to be higher in Asian countries; therefore, the establishment of treatment systems is even more important in this population. In addition to diazoxide or long- term subcutaneous infusion of octreotide or glucagon, long-acting octreotide or lanreotide have also been used successfully until spontaneous remission. Because of these medications, near-total pancreatectomy is less often performed even for the diazoxide-unresponsive diffuse form of CHI. Other promising medications include pasireotide, small-molecule correctors such as sulfonylurea or carbamazepine, GLP1 receptor antagonists, or mammalian target of rapamycin inhibitors. Unsolved questions in this field include the identification of the remaining genes responsible for CHI, the mechanisms leading to transient CHI, and the mechanisms responsible for the spontaneous remission of CHI. This article reviews recent developments and hypothesis regarding these questions.

Abstract

The diagnosis and treatment of congenital hyperinsulinism (CHI) have made a remarkable progress over the past 20 years and, currently, it is relatively rare to see patients who are left with severe psychomotor delay. The improvement was made possible by the recent developments in the understanding of the molecular and pathological basis of CHI. Known etiologies include inactivating mutations of the K ATP channel genes (ABCC8 and KCNJ11) and HNF4A, HNF1A, HADH, and UCP2 or activating mutations of GLUD1, GCK, and SLC16A1. The understanding of the focal form of K ATP channel CHI and its detection by 18 F-fluoro-L-DOPA positron emission tomography have revolutionized the management of CHI, and many patients can be cured without postoperative diabetes mellitus. The incidence of the focal form appears to be higher in Asian countries; therefore, the establishment of treatment systems is even more important in this population. In addition to diazoxide or long- term subcutaneous infusion of octreotide or glucagon, long-acting octreotide or lanreotide have also been used successfully until spontaneous remission. Because of these medications, near-total pancreatectomy is less often performed even for the diazoxide-unresponsive diffuse form of CHI. Other promising medications include pasireotide, small-molecule correctors such as sulfonylurea or carbamazepine, GLP1 receptor antagonists, or mammalian target of rapamycin inhibitors. Unsolved questions in this field include the identification of the remaining genes responsible for CHI, the mechanisms leading to transient CHI, and the mechanisms responsible for the spontaneous remission of CHI. This article reviews recent developments and hypothesis regarding these questions.

참고문헌 (100)

  1. Menni F, "Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia", Pediatrics, 107, pp.476~479 (2001)
  2. Steinkrauss L, "Effects of hypoglycemia on developmental outcome in children with congenital hyperinsulinism", J Pediatr Nurs, 20, pp.109~118 (2005)
  3. Ludwig A, "Glucose metabolism and neurological outcome in congenital hyperinsulinism", Semin Pediatr Surg, 20, pp.45~49 (2011)
  4. Avatapalle HB, "Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism", Front Endocrinol, 4, pp.60~ (2013)
  5. Shilyansky J, "Is 95%pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate?", J Pediatr Surg, 32, pp.342~346 (1997)
  6. Meissner T, "Long-term follow-up of 114 patients with congenital hyperinsulinism", Eur J Endocrinol, 149, pp.43~51 (2003)
  7. Levy-Shraga Y, "Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism", J Pediatr Endocrinol Metab, 26, pp.301~308 (2013)
  8. Hussain K, "Diagnosis and management of hyperinsulinaemic hypoglycaemia of infancy", Horm Res, 69, pp.2~13 (2008)
  9. Arnoux JB, "Congenital hyperinsulinism: current trends in diagnosis and therapy", Orphanet J Rare Dis, 6, pp.63~ (2011)
  10. Mohamed Z, "Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management", J Clin Res Pediatr Endocrinol, 4, pp.169~181 (2012)
  11. Palladino AA, "Hyperinsulinism in infancy and childhood: when an insulin level is not always enough", Clin Chem, 54, pp.256~263 (2008)
  12. De Leon DD, "Determination of insulin for the diagnosis of hyperinsulinemic hypoglycemia", Best Pract Res Clin Endocrinol Metab, 27, pp.763~769 (2013)
  13. Arnoux JB, "Congenital hyperinsulinism", Early Hum Dev, 86, pp.287~294 (2010)
  14. van Veen MR, "Metabolic profiles in children during fasting", Pediatrics, 127, pp.e1021~e1027 (2011)
  15. Vannucci RC, "Hypoglycemic brain injury", Semin Neonatol, 6, pp.147~155 (2001)
  16. Salhab WA, "Initial hypoglycemia and neonatal brain injury in term infants with severe fetal acidemia", Pediatrics, 114, pp.361~366 (2004)
  17. Rozance PJ, "Hypoglycemia in newborn infants:Features associated with adverse outcomes", Biol Neonate, 90, pp.74~86 (2006)
  18. Gataullina S, "Comorbidity and metabolic context are crucial factors determining neurological sequelae of hypoglycaemia", Dev Med Child Neurol, 54, pp.1012~1017 (2012)
  19. Ashcroft FM, "K(ATP) channels and islet hormone secretion: new insights and controversies", Nat Rev Endocrinol, 9, pp.660~669 (2013)
  20. Yorifuji T, "Congenital hyperinsulinism:global and Japanese perspectives", Pediatr Int Forthcoming (2014)
  21. Pearson ER, "Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene", PLoS Med, 4, pp.e118~ (2007)
  22. Kapoor RR, "Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations", Diabetes, 57, pp.1659~1663 (2008)
  23. Flanagan SE, "Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations", Eur J Endocrinol, 162, pp.987~992 (2010)
  24. Stanescu DE, "Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A", J Clin Endocrinol Metab, 97, pp.E2026~E2030 (2012)
  25. Colclough K, "Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia", Hum Mutat, 34, pp.669~685 (2013)
  26. Snider KE, "Genotype and phenotype correlations in 417 children with congenital hyperinsulinism", J Clin Endocrinol Metab, 98, pp.E355~E363 (2013)
  27. Kapoor RR, "Clinical and molecular characterisation of 300patients with congenital hyperinsulinism", Eur J Endocrinol, 168, pp.557~564 (2013)
  28. Sempoux C, "Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis", Endocr Pathol, 15, pp.241~246 (2004)
  29. Pinney SE, "Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations", J Clin Invest, 118, pp.2877~2886 (2008)
  30. Macmullen CM, "Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1", Diabetes, 60, pp.1797~1804 (2011)
  31. de Lonlay P, "Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy", J Clin Invest, 100, pp.802~807 (1997)
  32. Verkarre V, "Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia", J Clin Invest, 102, pp.1286~1291 (1998)
  33. Fournet JC, "Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11", Am J Pathol, 158, pp.2177~2184 (2001)
  34. Damaj L, "Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism", J Clin Endocrinol Metab, 93, pp.4941~4947 (2008)
  35. Suchi M, "Congenital hyperinsulinism:intraoperative biopsy interpretation can direct the extent of pancreatectomy", Am J Surg Pathol, 28, pp.1326~1335 (2004)
  36. Suchi M, "Molecular and immunohistochemical analyses of the focal form of congenital hyperinsulinism", Mod Pathol, 19, pp.122~129 (2006)
  37. Rahier J, "Morphologic analysis of focal and diffuse forms of congenital hyperinsulinism", Semin Pediatr Surg, 20, pp.3~12 (2011)
  38. -DOPA positron emission tomography, "Diabetes", 2006, 13~18
  39. Blomberg BA, "The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis", Mol Imaging Biol, 15, pp.97~105 (2013)
  40. Yang J, "Diagnostic role of 18F-dihydroxyphenylalanine positron emission tomography in patients with congenital hyperinsulinism: a meta-analysis", Nucl Med Commun, 34, pp.347~353 (2013)
  41. -fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan, "Clin Endocrinol", 2011, 342~346
  42. Glaser B, "Hyperinsulinism caused by paternal-specific inheritance of a recessive mutation in the sulfonylureareceptor gene", Diabetes, 48, pp.1652~1657 (1999)
  43. De Leon DD, "Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates", Nat Clin Pract Endocrinol Metab, 3, pp.57~68 (2007)
  44. Fernandez-Marmiesse A, "Mutation spectra of ABCC8 gene in Spanish patients with Hyperinsulinism of Infancy (HI)", Hum Mutat, 27, pp.214~ (2006)
  45. Sandal T, "The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy", Clin Genet, 75, pp.440~448 (2009)
  46. Yorifuji T, "Molecular and clinical analysis of Japanese patients with persistent congenital hyperinsulinism: predominance of paternally inherited monoallelic mutations in the KATP channel genes", J Clin Endocrinol Metab, 96, pp.E141~E145 (2011)
  47. Mohnike K, "Clinical and genetic evaluation of patients with KATP channel mutations from the German registry for congenital hyperinsulinism", Horm Res Paediatr, 81, pp.156~168 (2014)
  48. Su C, "Longterm follow-up and mutation analysis of 27 chinese cases of congenital hyperinsulinism", Horm Res Paediatr, 81, pp.169~176 (2014)
  49. Banerjee I, "The contribution of rapid KATP channel gene mutation analysis to the clinical management of children with congenital hyperinsulinism", Eur J Endocrinol, 164, pp.733~740 (2011)
  50. Stanley CA, "Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene", N Engl J Med, 338, pp.1352~1357 (1998)
  51. Molven A, "Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation", Diabetes, 53, pp.221~227 (2004)
  52. Flanagan SE, "Genome-wide homozygosity analysis reveals HADH mutations as a common cause of diazoxide-responsive hyperinsulinemic-hypoglycemia in consanguineous pedigrees", J Clin Endocrinol Metab, 96, pp.E498~E502 (2011)
  53. Heslegrave AJ, "Novel insights into fatty acid oxidation, amino acid metabolism, and insulin secretion from studying patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase", J Clin Endocrinol Metab, 98, pp.496~501 (2013)
  54. Kassem S, "Large islets, beta-cell proliferation, and a glucokinase mutation", N Engl J Med, 362, pp.1348~1350 (2010)
  55. Barbetti F, "Opposite clinical phenotypes of glucokinase disease: description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene", Mol Endocrinol, 23, pp.1983~1989 (2009)
  56. Christesen HB, "Activating glucokinase (GCK)mutations as a cause of medically responsive congenital hyperinsulinism: prevalence in children and characterisation of a novel GCK mutation", Eur J Endocrinol, 159, pp.27~34 (2008)
  57. Osbak KK, "Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia", Hum Mutat, 30, pp.1512~1526 (2009)
  58. Henquin JC, "Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of β-cells", Diabetes, 62, pp.1689~1696 (2013)
  59. Gonzalez-Barroso MM, "Mutations in UCP2in congenital hyperinsulinism reveal a role for regulation of insulin secretion", PLoS One, 3, pp.e3850~ (2008)
  60. Otonkoski T, "Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release", Diabetes, 52, pp.199~204 (2003)
  61. Kapoor RR, "Hyperinsulinism in developmental syndromes", Endocr Dev, 14, pp.95~113 (2009)
  62. Bitner-Glindzicz M, "A recessive contiguous gene deletion causing infantile hyperinsulinism, enteropathy and deafness identifies the Usher type 1C gene", Nat Genet, 26, pp.56~60 (2000)
  63. Al Mutair AN, "Heterogeneity in phenotype of usher-congenital hyperinsulinism syndrome:hearing loss, retinitis pigmentosa, and hyperinsulinemic hypoglycemia ranging from severe to mild with conversion to diabetes", Diabetes Care, 36, pp.557~561 (2013)
  64. Touati G, "Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria", Eur J Pediatr, 157, pp.628~633 (1998)
  65. Demirel F, "Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide", J Pediatr Endocrinol Metab, 24, pp.603~605 (2011)
  66. Yoshida K, "High prevalence of severe circulatory complications with diazoxide in premature infants", Neonatology, 105, pp.166~171 (2014)
  67. Glaser B, "Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy", J Pediatr, 123, pp.644~650 (1993)
  68. Thornton PS, "Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism", J Pediatr, 123, pp.637~643 (1993)
  69. Yorifuji T, "Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism", Clin Endocrinol, 78, pp.891~897 (2013)
  70. Koren I, "Hepatitis in an infant treated with octreotide for congenital hyperinsulinism", J Pediatr Endocrinol Metab, 26, pp.183~185 (2013)
  71. Laje P, "Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism", Pediatr Diabetes, 11, pp.142~147 (2010)
  72. Celik N, "Octreotide-induced long QT syndrome in a child with congenital hyperinsulinemia and a novel missense mutation (p.Met115Val) in the ABCC8 gene", Horm Res Paediatr, 80, pp.299~303 (2013)
  73. Mohnike K, "Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon", Horm Res, 70, pp.59~64 (2008)
  74. Neylon OM, "Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism", J Pediatr Endocrinol Metab, 26, pp.1157~1161 (2013)
  75. von Rohden L, "Visualization of the focus in congenital hyperinsulinism by intraoperative sonography", Semin Pediatr Surg, 20, pp.28~31 (2011)
  76. Adzick NS, "A multidisciplinary approach to the focal form of congenital hyperinsulinism leads to successful treatment by partial pancreatectomy", J Pediatr Surg, 39, pp.270~275 (2004)
  77. Palladino AA, "A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism", Semin Pediatr Surg, 20, pp.32~37 (2011)
  78. Laje P, "Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism", J Pediatr Surg, 47, pp.130~135 (2012)
  79. Barthlen W, "Congenital hyperinsulinism", Semin Pediatr Surg, 20, pp.1~2 (2011)
  80. Barthlen W, "Surgery in congenital hyperinsulinism-tips and tricks not only for surgeons: a practical guide", Semin Pediatr Surg, 20, pp.56~59 (2011)
  81. Proverbio MC, "Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism", PLoS One, 8, pp.e68740~ (2013)
  82. Flanagan SE, "Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation", Am J Hum Genet, 92, pp.131~136 (2013)
  83. Thompson LP, "Impact of oxidative stress in fetal programming", J Pregnancy, 2012, pp.582748~ (2012)
  84. Heinis M, "Oxygen tension regulates pancreatic beta-cell differentiation through hypoxia-inducible factor 1alpha", Diabetes, 59, pp.662~669 (2010)
  85. Hakim F, "High oxygen condition facilitates the differentiation of mouse and human pluripotent stem cells into pancreatic progenitors and insulin-producing cells", J Biol Chem, 289, pp.9623~9638 (2014)
  86. Wang G, "Preterm birth and random plasma insulin levels at birth and in early childhood", JAMA, 311, pp.587~596 (2014)
  87. Mazor-Aronovitch K, "Surgical versus non-surgical treatment of congenital hyperinsulinism", Pediatr Endocrinol Rev, 6, pp.424~430 (2009)
  88. Kassem SA, "Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy", Diabetes, 49, pp.1325~1333 (2000)
  89. Yorifuji T, "Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism", Horm Res Paediatr, 76, pp.286~290 (2011)
  90. Modan-Moses D, "Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel)", J Clin Endocrinol Metab, 96, pp.2312~2317 (2011)
  91. Kuhnen P, "Long-term lanreotide treatment in six patients with congenital hyperinsulinism", Horm Res Paediatr, 78, pp.106~112 (2012)
  92. Le Quan Sang KH, "Successful treatment of congenital hyperinsulinism with long-acting release octreotide", Eur J Endocrinol, 166, pp.333~339 (2012)
  93. de Heide LJ, "Treatment of severe postRYGB hyperinsulinemic hypoglycemia with pasireotide: a comparison with octreotide on insulin, glucagon, and GLP-1", Surg Obes Relat Dis (2013)
  94. Feelders RA, "Pasireotide, a multi-somatostatin receptor ligand with potential efficacy for treatment of pituitary and neuroendocrine tumors", Drugs Today, 49, pp.89~103 (2013)
  95. Martin GM, "Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels", Front Physiol, 4, pp.386~ (2013)
  96. Yan FF, "Sulfonylureas correct trafficking defects of disease-causing ATP-sensitive potassium channels by binding to the channel complex", J Biol Chem, 281, pp.33403~33413 (2006)
  97. Chen PC, "Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism", J Biol Chem, 288, pp.20942~20954 (2013)
  98. Calabria AC, "GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel", Diabetes, 61, pp.2585~2591 (2012)
  99. Gu Y, "Rictor", mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size, 2011, pp.60, 827~837
  100. Senniappan S, "Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia", N Engl J Med, 370, pp.1131~1137 (2014)

관련 논문AI추천

Pasireotide treatment for severe congenital hyperinsulinism due to a homozygous ABCC8 mutationBarthlen Winfried, Bikker Hennie, Mohnike Klaus, Mooij Christiaan F., Oomen Matthijs W.N., Tacke Carline E., van Albada Mirjam E., van Trotsenburg A.S. Paul, Zwaveling-Soonawala Nitash대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2021 · 제26권 제4호Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8Antoniou Maria Christina, Bouthors Thérèse, Brusgaard Klaus, Busiah Kanetee, Christesen Henrik Thybo, Dwyer Andrew, Hauschild Michael, Hussain Khalid, Jacot Eric, Mouron-Hryciuk Julie, Roth-Kleiner Matthias, Stoppa-Vaucher Sophie대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2021 · 제26권 제1호Congenital hyperinsulinism: diagnostic and management challenges in a developing country – case reportCheri Mathews John, Prakash Agarwal, Sandhya Sundaram, Senthil Senniappan, Suriyakumar Govindarajulu대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2017 · 제22권 제4호Using low-dose octreotide with diazoxide-resistant congenital hyperinsulinism resulting from compound heterozygous mutations in the ABCC8 geneHwang Jin Soon, Lee Hae Sang, Lim Kyung In, Park Kyujung, Sohn Young BaeNeonatal Diabetes Mellitus Due to KCNJ11 (KIR6.2) Mutation Successfully Treated with Sulfonylurea성세인, 안소윤, Misun Yang, Sehun Jang, Won Soon Park, Yun Sil Chang대한신생아학회 · Neonatal medicine2021 · 제28권 제2호Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11박규정, 손영배, 윤종서, 이해상, 황진순대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2018 · 제23권 제3호

이 간행물의 다른 논문 (9건)

Phthalate exposure and childhood obesity박미정, 김신혜pp. 67-75Thyroid autoimmunity in children and adolescents with newly diagnosed type 1 diabetes mellitus한동균, 이대열, 정의석, 양은미, 김민선, 김찬종pp. 76-79Fasting serum C-peptide is useful for initial classification of diabetes mellitus in children and adolescents이대열, 김은영, 김민선, 김종덕, 김찬종, 조민정pp. 80-85Vitamin D deficiency in Korean children: prevalence, risk factors, and the relationship with parathyroid hormone levels김해중, 황인혁, 정소정, 유은경pp. 86-90Associations between serum vitamin D levels and precocious puberty in girls황진순, 정활림, 심영석, 권은별, 김유진, 이해상pp. 91-95
원문 보기